Correction to: Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease
- PMID: 35416618
- PMCID: PMC9124247
- DOI: 10.1007/s40121-022-00618-8
Correction to: Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease
Erratum for
-
Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease.Infect Dis Ther. 2022 Feb;11(1):367-387. doi: 10.1007/s40121-021-00573-w. Epub 2021 Dec 7. Infect Dis Ther. 2022. PMID: 34877641 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
